Data as of Apr 17
| +0.67 / +1.30%|
The 26 analysts offering 12-month price forecasts for Sanofi SA have a median target of 56.34, with a high estimate of 65.97 and a low estimate of 46.46. The median estimate represents a +7.65% increase from the last price of 52.34.
The current consensus among 30 polled investment analysts is to Buy stock in Sanofi SA. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.